Optimizing the Safety-Efficacy Equation for Comprehensive Glycemic Regulation in Complex Patients with T2D—The Physiologic Rationale for Complementary Pharmacologic Approaches Based on Insulin plus Incretin System-Targeting Agents

Optimizing the Safety-Efficacy Equation for Comprehensive Glycemic Regulation in Complex Patients with T2D—The Physiologic Rationale for Complementary Pharmacologic Approaches Based on Insulin plus Incretin System-Targeting Agents


Published

June 28, 2017

Created by

CMEducation Resources symposium

Related Presenters

Vivian Fonseca, FRCP, MD

Vivian Fonseca, FRCP, MD

Professor of Medicine and Pharmacology
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
Past President, Science and Medicine American Diabetes Association (ADA)